- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/14 - Radicals substituted by nitrogen atoms, not forming part of a nitro radical
Patent holdings for IPC class C07D 209/14
Total number of patents in this class: 829
10-year publication summary
|
55
|
65
|
43
|
60
|
39
|
39
|
42
|
46
|
40
|
25
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Achillion Pharmaceuticals, Inc. | 164 |
23 |
| Katholieke Universiteit Leuven | 1227 |
21 |
| Generics [UK] Limited | 115 |
20 |
| Janssen Pharmaceuticals, Inc. | 442 |
16 |
| Novartis AG | 10612 |
13 |
| Adeka Corporation | 1367 |
11 |
| Pacific Biosciences of California, Inc. | 757 |
10 |
| The Board of Trustees of the University of Illinois | 2724 |
9 |
| Redwood BioScience, Inc. | 31 |
9 |
| The Johns Hopkins University | 5756 |
8 |
| Mylan Development Centre Private Limited | 12 |
8 |
| Rutgers, The State University of New Jersey | 1934 |
8 |
| The Regents of the University of California | 20303 |
7 |
| Janssen Pharmaceutica N.V. | 3358 |
7 |
| Life Technologies Corporation | 3351 |
7 |
| Neoculi Pty Ltd | 18 |
7 |
| PMV Pharmaceuticals, Inc. | 45 |
7 |
| Caamtech, Inc. | 151 |
7 |
| The General Hospital Corporation | 4801 |
6 |
| Vertex Pharmaceuticals Incorporated | 1630 |
6 |
| Other owners | 619 |